We are live on
!
Find out more
FI
Focused Investors Portfolio holdings
AUM
$2.96B
1-Year Est. Return
15.6%
This Fund
S&P 500
This Quarter
Est. Return
+12.23%
1 Year Est. Return
+15.6%
3 Year Est. Return
+51.26%
5 Year Est. Return
+77.43%
10 Year Est. Return
+309.27%
AUM
$3.1B
AUM Growth
+$311M
(+11%)
Cap. Flow
-$9.43M
Cap. Flow
% of AUM
-0.3%
Top 10 Holdings %
Top 10 Hldgs %
57.67%
Holding
23
New
–
Increased
5
Reduced
18
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$24.9M |
| 2 |
PepsiCo
PEP
|
+$2.68M |
| 3 |
Coca-Cola
KO
|
+$1.44M |
| 4 |
Northrop Grumman
NOC
|
+$1.04M |
| 5 |
Cigna
CI
|
+$190K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$13.8M |
| 2 |
Elevance Health
ELV
|
+$11.9M |
| 3 |
Johnson & Johnson
JNJ
|
+$2.31M |
| 4 |
FedEx
FDX
|
+$1.48M |
| 5 |
McDonald's
MCD
|
+$1.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.1% |
| 2 | Industrials | 17.21% |
| 3 | Technology | 13.99% |
| 4 | Consumer Discretionary | 13.66% |
| 5 | Financials | 11.84% |
Similar funds
SSM
VGM
CSIC
BCF
PHAM
SP
B
NC
Focused Investors's Q4 2022 Portfolio in Review
As of Q4 2022, Focused Investors held 23 positions worth $3.1B, up 11% from $2.79B the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Trading was light in Q4 2022: portfolio turnover was 0%. Focused Investors opened no new positions and made no exits, leaving the 23-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Industrials and Technology.
- Focused Investors added most to Oracle in Q4 2022, an estimated $24.9M increase.
- Focused Investors's biggest Q4 2022 reduction was UnitedHealth, cutting an estimated $13.8M.
- Focused Investors's ten largest holdings make up 58% of its $3.1B portfolio in Q4 2022.
- Focused Investors opened 0 new positions and closed 0 in Q4 2022.
- Focused Investors's portfolio value rose 11% quarter-over-quarter to $3.1B.
Based on Focused Investors's 13F filing for Q4 2022, filed 25 Jan 2023.